Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 2
1975 4
1976 3
1977 5
1978 1
1979 1
1980 9
1981 4
1982 13
1983 7
1984 5
1985 9
1986 4
1987 10
1988 22
1989 10
1990 9
1991 12
1992 8
1993 10
1994 11
1995 15
1996 4
1997 12
1998 3
1999 10
2000 7
2001 9
2002 2
2003 7
2004 8
2005 14
2006 4
2007 3
2008 2
2009 1
2010 2
2011 1
2015 2
2016 4
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Results by year

Filters applied: . Clear all
Page 1
Update on the use of ciclosporin in immune-mediated dermatoses.
Griffiths CE, Katsambas A, Dijkmans BA, Finlay AY, Ho VC, Johnston A, Luger TA, Mrowietz U, Thestrup-Pedersen K. Griffiths CE, et al. Among authors: thestrup pedersen k. Br J Dermatol. 2006 Jul;155 Suppl 2:1-16. doi: 10.1111/j.1365-2133.2006.07343.x. Br J Dermatol. 2006. PMID: 16774579 Review.
[Atopic dermatitis].
Thestrup-Pedersen K. Thestrup-Pedersen K. Ugeskr Laeger. 1997 Oct 13;159(42):6195. Ugeskr Laeger. 1997. PMID: 9381587 Danish. No abstract available.
T lymphocyte chemotaxis and skin diseases.
Tan J, Thestrup-Pedersen K. Tan J, et al. Among authors: thestrup pedersen k. Exp Dermatol. 1995 Oct;4(5):281-90. doi: 10.1111/j.1600-0625.1995.tb00206.x. Exp Dermatol. 1995. PMID: 8589918 Review.
Consensus statement on the safety profile of topical calcineurin inhibitors.
Bieber T, Cork M, Ellis C, Girolomoni G, Groves R, Langley R, Luger T, Meurer M, Murrell D, Orlow S, Paller A, de Prost Y, Puig L, Ring J, Saurat JH, Schwarz T, Shear N, Stingl G, Taieb A, Thestrup-Pedersen K; Pediatric Advisory Committee of the Food and Drug Administration. Bieber T, et al. Among authors: thestrup pedersen k. Dermatology. 2005;211(2):77-8. doi: 10.1159/000086431. Dermatology. 2005. PMID: 16088148 No abstract available.
Treatment principles of atopic dermatitis.
Thestrup-Pedersen K. Thestrup-Pedersen K. J Eur Acad Dermatol Venereol. 2002 Jan;16(1):1-9. doi: 10.1046/j.1468-3083.2002.00349.x. J Eur Acad Dermatol Venereol. 2002. PMID: 11952283 Review.
Clinical aspects of atopic dermatitis.
Thestrup-Pedersen K. Thestrup-Pedersen K. Clin Exp Dermatol. 2000 Oct;25(7):535-43. doi: 10.1046/j.1365-2230.2000.00696.x. Clin Exp Dermatol. 2000. PMID: 11122225 Review.
The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, Stalder JF, Thestrup-Pedersen K; European Working Group on Atopic Dermatitis. Alomar A, et al. Among authors: thestrup pedersen k. Br J Dermatol. 2004 Dec;151 Suppl 70 Dec 2004:3-27. doi: 10.1111/j.1365-2133.2004.06269.x. Br J Dermatol. 2004. PMID: 15548171 Review.
270 results